280 The pathogenesis, disease progression rate, and treatment responses of SONFH between men and women also remain to be further studied
Unless they're part of an active investigation by the FDA, Ingrassia said, U.S
[12] This differs significantly from intravenous injections, where air bubbles could theoretically pose risks
As illustrated, considerable variation exists across studies in dose, route, and duration, making it difficult to directly compare efficacy across disease models or predict human dose equivalence
The regulator said semaglutide may be associated with non-arteritic anterior ischemic optic neuropathy, or NAION, a condition that affects the optic nerve and typically causes sudden, painless loss of vision in one eye
This is where your next chapter starts